TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Djurfarmacia Sverige AB
Closing information (x1000 EUR)
| Closing information | 2025/08 | 2024/08 | 2023/08 |
| Turnover |
50,377
|
41,109
|
35,383 |
| Financial expenses |
0
|
3
|
24 |
| Earnings before taxes |
2,635
|
2,188
|
1,677 |
| EBITDA |
2,929
|
2,443
|
1,939 |
| Total assets |
12,557
|
10,500
|
9,214 |
| Current assets |
10,588
|
8,431
|
7,167 |
| Current liabilities |
5,201
|
4,329
|
4,140 |
| Equity capital |
6,918
|
5,731
|
4,681 |
| - share capital |
9
|
9
|
8 |
| Employees (average) |
48
|
44
|
53 |
Financial ratios
| Fiscal year | 2025/08 | 2024/08 | 2023/08 |
| Solvency |
55.1%
|
54.6%
|
50.8% |
| Turnover per employee |
1,050
|
934
|
668 |
| Profit as a percentage of turnover |
5.2%
|
5.3%
|
4.7% |
| Return on assets (ROA) |
21.0%
|
20.9%
|
18.5% |
| Current ratio |
203.6%
|
194.8%
|
173.1% |
| Return on equity (ROE) |
38.1%
|
38.2%
|
35.8% |
| Change turnover |
8,224
|
4,141
|
4,918 |
| Change turnover % |
20%
|
11%
|
16% |
| Chg. No. of employees |
4
|
-9
|
6 |
| Chg. No. of employees % |
9%
|
-17%
|
13% |
Total value of public sale
| Fiscal year | 2025/08 | 2024/08 | 2023/08 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.